Independent research on the U.S. markets, Baptista Research

Baptista Research

Independent research on the U.S. markets

Baptista Research is an independent financial research house focused on the U.S. markets. We provide equity research as well as credit research reports on the top-listed U.S. companies with most of our focus on technology, consumer goods and services, automobiles, industrials, oil and gas, pharma, and healthcare. Our research has served more than 3000 institutional investors including mutual funds, hedge funds, banks, family offices, and various buy-side firms. We operate a research subscription service where institutions, as well as retail investors, can have priority access to all our research. We also have a wide distribution of our research reports across some of the top global financial platforms. Apart from equity research and credit research, we also provide advisory services with respect to mergers & acquisitions (M&A), private equity/ venture capital fundraising, valuation reports, and investment management services for corporates.
Baptista Research is owned and managed by Ishan Majumdar, an ex-Venture Capitalist/ Investment Banker, a Chartered Accountant, and a Masters’ degree holder in Management from HEC Paris. Ishan has nearly a decade of experience in Mergers and Acquisitions, Leveraged Buyouts (LBOs), Venture Capital Investing, Corporate Strategy, and Valuation in front-office roles at the likes of BNP Paribas CIB, Credit Agricole CIB, Groupe Danone, and TIW Private Equity. He has worked on and closed multiple acquisition deals, leveraged buyouts, and start-up investment transactions.

Equity Bottom-Up

<ul><li>HCA Healthcare's recent earnings call for Q1 2025 presents a nuanced picture of the company's performance and strategic position.</li><li>The company recorded strong financial results based on consistent volume growth, an improved payer mix, and increased operating margin.</li><li>Diluted earnings per share also saw a notable 20% increase, reaching $6.45.</li></ul>

HCA Healthcare's recent earnings call for Q1 2025 presents a nuanced picture of the company's performance and strategic position.The company recorded strong financial results based on consistent volume growth, an improved payer mix, and increased operating margin.Diluted earnings per share also saw a notable 20% increase, reaching $6.45.

HCA Healthcare: An Insight Into The Labor Market Dynamics & Wage Trends & Vital Factors Driving Growth!

Head of Research, Krungthai XSpring

Waraporn Wiboonkanarak

Head of Research

A full service Thai brokerage

Krungthai XSpring

Krungthai XSpring is a full service broker. The company provides a wide range of investment services such as Securities Brokerage, Derivative Agent Business, Securities Borrowing and Lending, Securities Trading, Underwriting, Financial Advisory, Wealth Advisory, Private Fund Management and International Markets Securities Trading. 

In terms of credibility, Fitch Ratings has assigned Krunghtai XSpring a long-term rating of AA- and a national short-term rating of F1+ with stable outlook.

PTT Exploration & Production / Equity Bottom-Up

<ul><li>Technically, the SET Index is expected to move in a sideways-down pattern, with the support levels at 1,143 points (10-day EMA) and 1,133 points and the resistance levels at 1,156 points (25-day EMA) and 1,164 points.</li><li>In the short term, the index remains in a bullish flag rally phase, aiming to retest the previous resistance at 1,176 points after hitting a new low for the year at 1,056.41 on April 8.</li><li>This upward movement is expected to be short-lived, followed by a larger correction that would confirm a medium-term trend reversal into a new upward cycle (with a higher low).</li></ul>

Technically, the SET Index is expected to move in a sideways-down pattern, with the support levels at 1,143 points (10-day EMA) and 1,133 points and the resistance levels at 1,156 points (25-day EMA) and 1,164 points.In the short term, the index remains in a bullish flag rally phase, aiming to retest the previous resistance at 1,176 points after hitting a new low for the year at 1,056.41 on April 8.This upward movement is expected to be short-lived, followed by a larger correction that would confirm a medium-term trend reversal into a new upward cycle (with a higher low).

<ul><li>HCA Healthcare delivered a mixed performance in its fourth-quarter 2024 results, reflecting both strengths and challenges faced during the period.</li><li>Positively, the company continued to demonstrate robust demand for healthcare services, with an overall revenue growth of approximately 6% compared to the previous year.</li><li>Key performance indicators like inpatient admissions showed a healthy upward trajectory, with a 3% increase in both categories when measured on a same-facility basis.</li></ul>

HCA Healthcare delivered a mixed performance in its fourth-quarter 2024 results, reflecting both strengths and challenges faced during the period.Positively, the company continued to demonstrate robust demand for healthcare services, with an overall revenue growth of approximately 6% compared to the previous year.Key performance indicators like inpatient admissions showed a healthy upward trajectory, with a 3% increase in both categories when measured on a same-facility basis.

HCA Healthcare’s New Revenue Strategy: Inside The Government Policies & Critical Factors Powering Its Growth!

<ul><li>HCA Healthcare concluded the fourth quarter of 2024 with robust business fundamentals, maintaining consistency with previous quarters.</li><li>The company displayed resilience amidst challenges, such as significant weather disruptions caused by hurricanes, and a stable operational environment underpinned a reasonable starting point for 2025.</li><li>The execution of efficient operational strategies has allowed the organization to stabilize operations in affected regions like North Carolina, Georgia, and West Florida.</li></ul>

HCA Healthcare concluded the fourth quarter of 2024 with robust business fundamentals, maintaining consistency with previous quarters.The company displayed resilience amidst challenges, such as significant weather disruptions caused by hurricanes, and a stable operational environment underpinned a reasonable starting point for 2025.The execution of efficient operational strategies has allowed the organization to stabilize operations in affected regions like North Carolina, Georgia, and West Florida.

HCA Healthcare: Health Insurance Exchange Growth Driving Our ‘Outperform’ Rating! - Major Drivers

<ul><li>HCA Healthcare recently held its third-quarter earnings call, and the insights provided offer a complex view of the company’s current position and future outlook.</li><li>The financial results reflected strong performance despite notable challenges, particularly from recent hurricanes.</li><li>Positively, HCA Healthcare reported substantial year-over-year growth in several key financial metrics.</li></ul>

HCA Healthcare recently held its third-quarter earnings call, and the insights provided offer a complex view of the company’s current position and future outlook.The financial results reflected strong performance despite notable challenges, particularly from recent hurricanes.Positively, HCA Healthcare reported substantial year-over-year growth in several key financial metrics.

HCA Healthcare: The Volume Growth & Payer Mix Dynamics! - Major Drivers

United States

HCA Healthcare, Inc.  operates hospitals.  The Company operates acute care hospitals, outpatient facilities, clinics and other patient care delivery settings.  HCA operates hospitals in the United States and the United Kingdom.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

HCA Healthcare, Inc. (HCA US)

HCA Healthcare: An Insight Into The Labor Market Dynamics & Wage Trends & Vital Factors Driving Growth!

HCA Healthcare's recent earnings call for Q1 2025 presents a nuanced picture of the company's performance and strategic position. The company...

Baptista Research

Earnings Results of PTTEP and DELTA

Technically, the SET Index is expected to move in a sideways-down pattern, with the support levels at 1,143 points (10-day EMA) and 1,133 points...

Krungthai XSpring

HCA Healthcare’s New Revenue Strategy: Inside The Government Policies & Critical Factors Powering Its Growth!

HCA Healthcare delivered a mixed performance in its fourth-quarter 2024 results, reflecting both strengths and challenges faced during the...

Baptista Research

HCA Healthcare: Health Insurance Exchange Growth Driving Our ‘Outperform’ Rating! - Major Drivers

HCA Healthcare concluded the fourth quarter of 2024 with robust business fundamentals, maintaining consistency with previous quarters. The company...

Baptista Research

HCA Healthcare: The Volume Growth & Payer Mix Dynamics! - Major Drivers

HCA Healthcare recently held its third-quarter earnings call, and the insights provided offer a complex view of the company’s current position and...

Baptista Research

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)